51
Growth Score
pts
Heat Score
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1023897
AdCure Bio develops immuno-stimulatory oncolytic adenoviruses for metastatic cancer treatment.
- Dmitry Shayakhmetov: Co-Founder and Chief Scientific Officer
About the Company
AdCure Bio specializes in the field of biotechnology, focusing on the development of innovative cancer treatments. The company is dedicated to advancing the research and application of immuno-stimulatory oncolytic adenoviruses, targeting metastatic cancers. With a commitment to creating potent and safe therapies, AdCure Bio aims to contribute
significantly to the oncology sector by harnessing the power of viro-immuno-therapy. Their research efforts are centered around the Ad5/35-3M virus, a key component in their therapeutic strategy.
